This diary entry from R&D software provider, IDBS, looks at how individuals, laboratories and external collaborators can make their work more accurate with the help of cloud-based software.
Neil Pullman, principal architect at, Boulting Environmental Services, explores the differences between BIM Levels, their benefits and what it means for the pharmaceutical sector.
As pressure to get drugs to the human clinical trial stage increases more companies are looking to outsource not only non-core functions but major areas of R&D. Here, Praveen C. Surana, ELC Group, examines outsourcing projects in more detail.
Apps are ever more popular and becoming part of daily routine and lifestyle in this digital age, but how are pharma companies measuring up in this space?
The US Food and Drug Administration (FDA) has issued a warning letter to Meridian Medical Technologies, concerning the manufacture of epinephrine auto injectors.
The latest report from business information and analytics provider, GlobalData, has indicated that immune-oncology (IO) will become the fifth pillar of cancer treatment, joining surgery, radiotherapy, chemotherapy and other targeted treatments.
President of FIP, Dr Carmen Peña, has stated investment in the pharma sector is required to ensure universal health coverage, at the opening of the 77th World Congress of Pharmacy and Pharmaceutical Sciences in Seoul, Republic of Korea.
In this next instalment of our ‘Meet the maker’ series, we talk with Wendy Dwyer who was recently appointed as chief business officer of Portal Instruments — a Series B funded, clinical stage medical device company focused on advanced drug delivery.
Recent research from serialisation software provider, SEA Vision, and life sciences technology firm, Zenith Technologies, has revealed that for the majority of industry professionals the cost of implementing serialisation is the biggest barrier
According to a survey published by the manufacturers’ organisation, EEF, and accountancy and business advisory firm BDO, manufacturer’s in Britain are experiencing buoyant conditions as a result of the strengthening export markets.
Industry have responded favourably to the publication of the government’s Life Sciences Industrial Strategy today, which is aimed at helping the sector become an international benchmark for success.
